PremiumCompany AnnouncementsShanghai Fosun Pharmaceutical Announces AGM with Key Resolutions Fosun Pharma Announces 2025 Shareholders Meeting to Discuss Share Repurchase Mandates Fosun Pharma’s Subsidiary Drug Receives Breakthrough Therapy Designation PremiumCompany AnnouncementsShanghai Fosun Pharma Announces Board Restructuring and Governance Enhancements Shanghai Fosun Pharmaceutical Announces Board Composition and Committee Roles Shanghai Fosun Pharma Completes First Tranche of 2025 Medium-Term Notes PremiumCompany AnnouncementsShanghai Fosun Pharmaceutical Adjusts Share Capital through Repurchase and Cancellation Fosun Pharma Subsidiary Gains Approval for Schizophrenia Drug Trial Fosun Pharma Expands Stake in United Health Insurance